An Efficient Computational Model to Predict the Synthetic Utility of Heterocyclic Arynes

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

WILEY-V C H VERLAG GMBH

1. NIH-NIGMS [R01 GM090007]
2. NSF [CHE-0548209]
3. Boehringer Ingelheim
4. DuPont
5. Eli Lilly
6. Amgen
7. AstraZeneca
8. University of California, Los Angeles
9. Bristol-Myers Squibb
10. Pfizer
11. Christopher S. Foote Fellowship
12. Stauffer Charitable Trust
13. John Fell Oxford University Press
14. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090007] Funding Source: NIH RePORTER